BORR vs BP

BORR's Piotroski F-Score of 4/9 indicates borderline financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. The stock trades below its Graham Number of $5.01 at $4.47, suggesting modest undervaluation, though forward P/E of -47.51 signals expected earnings deterioration. Strong operating and gross margins contrast with high debt/equity of 1.80 and inconsistent earnings growth, particularly the recent Q/Q EPS decline of -35.7%. Technical trend is weak at 10/100, but dividend strength and insider sentiment are below average, contributing to a cautious outlook.

BP's Advanced Deterministic Scorecard shows a Piotroski F-Score of 6/9, indicating stable financial health, but the absence of an Altman Z-Score limits distress risk assessment. The stock trades at a significant premium to its Graham Number ($7.35) and even the growth-based intrinsic value ($18.88), currently priced at $36.53, driven by high forward earnings expectations. While profitability metrics and dividend yield are attractive, elevated valuation multiples, inconsistent earnings surprises, and a dangerously high payout ratio of 315% raise sustainability concerns. Analysts recommend a 'buy' with a target of $38.73, supported by strong insider sentiment, though no insider transactions have occurred recently.